This is not surprising, since chronic myelogenous leukemia cells rely on aberrant activation of NF-κB [18], and EF-24 efficiently suppresses NF-κB signaling through direct inhibition of IKK [5,12]. The gene discussed is NFKB1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.